About the 2018 Astellas Oncology C3 Prize

About the Astellas Oncology C3 Prize

What is the Astellas Oncology C3 Prize?

The Astellas Oncology C3 Prize is a global challenge designed to inspire innovative non-treatment ideas that may improve the lives of cancer patients, caregivers, and their loved ones, especially in low- and middle-income countries.

Winning applicants in three categories will receive grants and access to resources to make their life-changing ideas a reality.

Three prizes will be awarded as follows: one $50,000 grant and two $25,000 grants. These grants are meant to help winners further develop their ideas and bring them to life. Additionally, Astellas may also, at its sole discretion, assist winners in developing their idea. The three grant winners will also receive a one-year membership to MATTER, a Chicago-based healthcare technology incubator.

The Astellas Oncology C3 Prize is subject to all applicable federal, state, provincial and local laws and regulations. Astellas reserves the right to change, alter, or modify these rules and/or dates at any time without notice.

What sort of ideas is the Astellas Oncology C3 Prize looking for?

The Astellas Oncology C3 Prize is looking for ideas to develop new innovations that address a major issue in cancer care, specifically, challenges encountered in low- and middle-income countries. Potential issues to address include, but are not limited to, the following:

  • Navigation – Innovative tools, methods or processes are needed to help guide patients living with cancer and their loved ones through the healthcare system and to reduce the burden of decision making, so that patients are able to better focus on their personal health.
  • Adherence – Innovative tools, methods or processes are needed to help patients living with cancer be more successful in adhering to a treatment plan and to help increase medication compliance.
  • Care Coordination – Innovative tools, methods or processes are needed to provide clarity and ease to patients living with cancer and caregivers around improving how care is networked, coordinated and delivered.
  • Survivorship – Innovative tools, methods or processes are needed to develop support systems for patients, caregivers and others impacted by cancer as more people live longer with the disease or live longer cancer-free.

Entrants should let us know what they think the biggest problem is, their idea/solution and the potential impact of that idea/solution in the cancer community, specific to low- and middle-income countries.

Learn more about last year's winners and their ideas.

What categories can submissions be entered in?

This year's program categories include:

  • Support Tools – For cancer patients, caregivers and physicians who have access to the Internet, there are a number of available online support tools, such as support groups and forums. However, in low- and middle-income countries, patients may not be able to access these online tools and need to receive support in a different way. Entries in this category seek to provide patients around the world with access to support resources. Submission ideas can include tools, methods or processes that help create support systems or provide support and encouragement for patients, caregivers and others impacted by cancer; can include support in navigating the system and/or adhering to a treatment plan.
  • Educational Tools – A cancer diagnosis is a life-changing event, but many patients do not have the information they need to make the most of the resources that may be available to them. Educational tools help patients learn about cancer, the treatment process, and available resources. This is especially important in low- and middle-income countries, where educational awareness programs about cancer may be less prevalent. Submission ideas can include tools, methods or processes that educate patients, caregivers and others impacted by cancer, through all aspects of the journey, whether that be at the time of a diagnosis, during treatment or post-treatment.
  • Technology – More people than ever before are connected by mobile devices and the Internet, and tools that make the most of this can help patients and caregivers in low- and middle-income countries better manage cancer treatment and recovery. Any technological device, digital health tool or app will fall into this category.

What if my idea falls into more than one category?

Submissions may only be entered into one category. We suggest you pick the category that you believe best fits the problem your idea is trying to solve, and the method by which the solution is delivered.

What if I don't feel like any of the given categories fit my idea?

All submissions must fit into a category. We recommend selecting the category that you feel most closely aligns with your idea. Per the terms and conditions, 15% of the applicant's score is based on adherence to the category, the remaining 85% of the score is based on the merits of the idea and its ability to be operationalized.

Application Requirements and Deadlines

When does the Astellas Oncology C3 Prize contest begin and when will the winners be announced?

The timing for the Astellas Oncology C3 Prize is as follows:

  • The Challenge will open on May 30, 2018 and will accept entries through July 25, 2018.
  • Three category winners will be selected and notified on or about August 24, 2018 and invited to pitch their ideas, at no cost, in front of a live panel of judges at the UICC World Cancer Congress on October 3, 2018 in Kuala Lumpur.
  • The grand prize winner of the Astellas Oncology C3 Prize will be announced at the closing reception of the UICC World Cancer Congress in Kuala Lumpur on October 4, 2018.

Who is eligible to apply?

To be eligible to enter the Challenge, you must: (1) be above the age of majority in the country, state, province, or jurisdiction of residence (and at least twenty (20) years old in Taiwan) at the time of entry; (2) not be a resident of Brazil, Crimea, Cuba, Iran, Syria, North Korea, Sudan and where prohibited by law; (3) not be a person or entity under U.S. export controls or sanctions; and (4) have access to the Internet as of May 30, 2018.

Please see our Terms & Conditions for all eligibility information.

Individuals and/or groups may apply. It is not necessary for Entrants to have taken, currently take, or intend to take in the future, any medicine or product marketed by Astellas, and this will not be a consideration in the selection criteria.

It is not necessary for Healthcare Provider Entrants to prescribe, or intend to prescribe in the future, any medicine or product marketed by Astellas, and this will not be a consideration in the selection criteria.

Submission guidelines are included in the application. By participating, Entrants agree to these terms and conditions and the decisions of the judges and/or sponsors, which are binding and final on matters relating to this challenge.

Who is not eligible to apply?

Employees, interns, contractors and official office-holders of Astellas Pharma Inc., its subsidiaries, affiliates and their respective directors, officers, employees, advertising and promotion agencies, representatives and agents, and their immediate families (parents, siblings, children, spouses and life partners of each, regardless of where they live) and members of the households (whether related or not) of such employees, officers and directors are ineligible to participate in this Challenge. Please see our Terms & Conditions for all eligibility information.

How do I apply for the Challenge?

The application period is now closed and judging is currently underway.

How many times can I apply?

Only one application per individual or group will be accepted.

Winner Selection and Prize Rules

How many winners will be selected? How will we know who has won?

Three category winners will be invited to pitch their ideas live and all will be awarded grants, with one grand prize winner selected following the live pitch. The Astellas Oncology C3 Prize milestones are as follows:

  • The Challenge will open on May 30, 2018.
  • Three category winners will be invited to pitch their ideas in front of a live panel of judges at the UICC World Cancer Congress on October 3, 2018.

The grand prize winner of the Astellas Oncology C3 Prize will be announced at the closing reception of the UICC World Cancer Congress on October 4, 2018.

What will the winner(s) of the Astellas Oncology C3 Prize receive?

Three prizes will be awarded: One grand prize winner will receive a $50,000 grant. The remaining two category winners will each be awarded a $25,000 grant. These grants are meant to help winners further develop their ideas and bring them to life. Additionally, Astellas may also, at its sole discretion, assist winners in developing their idea. All three grant winners will also receive a one-year membership to MATTER, the Chicago-based healthcare technology incubator.

How can the 2018 Astellas Oncology C3 Prize grant money be used?

The Astellas Oncology C3 Prize grant can be used to bring the winners' ideas to life. The Challenge winners will develop a project plan detailing how they intend to use their grant and representatives of the Astellas Oncology C3 Prize may support this work along the way.

What is the MATTER membership?

MATTER is built for entrepreneurs and innovators in the fields of medical device, healthcare IT, medical diagnostics and biopharmaceuticals who are looking for flexible, affordable co-working space, mentoring and resources with which to grow their companies. MATTER's one-year nights and weekends membership will vary based on location of winners, but will include perks such as access to MATTER, use of community workspaces and access to the MATTER mentor network. For more information, visit www.matterchicago.com.

Who chooses the finalists and grand prize winner?

Online forms, videos and live presentations will be judged by a panel of experts.

How will the finalists and grand prize winner be selected?

Online forms, videos and live presentations will be evaluated by the judges based on the following criteria: extent to which idea reflects application category (15%); plausibility of idea (30%); creativity and originality of innovation (30%); and ability of Entrant to operationalize/implement the innovative idea for future application (25%). All decisions made by the judging panel are final. See the Terms & Conditions for more information on judging criteria.

If I have questions that aren't addressed here, where can I get more information?

If you have additional questions, please contact the program administrator at C3Prize@astellas.com.

Read the Terms & Conditions